chronic%20coronary%20syndromes
CHRONIC CORONARY SYNDROMES
Chronic coronary syndromes, also called stable coronary artery disease (CAD), stable ischemic heart disease (SIHD), chronic stable angina or stable angina pectoris, is a clinical syndrome characterized by squeezing, heaviness or pressure discomfort in the chest, neck, jaw, shoulder, back, or arms which is usually precipitated by exertion and/or emotional stress and relieved by rest and/or Nitroglycerin.
It is caused by myocardial ischemia that is commonly associated with narrowing of the coronary arteries.
Angina is stable when it is not a new symptom and when there is no deterioration in frequency, duration or severity of episodes.

Chronic Coronary Syndromes Drug Information

Drug Information

Indication: Symptomatic treatment of chronic stable angina pectoris in CAD adults w/ normal sinus rhythm & heart rate&...

Indication: Substitution treatment of essential HTN &/or stable CAD in patients already controlled w/ perindopril &...

Indication: HTN. Stable CAD: Risk reduction of cardiac events in patients w/ history of MI &/or revascularisation. 5 m...

Indication: Add-on therapy for symptomatic treatment in adults w/ stable angina pectoris who are inadequately controlled b...

Azoren
amlodipine besylate + olmesartan medoxomil

Indication: Essential HTN in patient whose BP is inadequately controlled on olmesartan medoxomil or amlodipine monotherapy...

Indication: HTN. Reduce risk of stroke in patients w/ HTN & left ventricular hypertrophy (LVH). Diabetic nephropathy w...

Indication: HTN for patients in whom combination therapy is appropriate. Reduce the risk of stroke in patients w/ HTN &...

Indication: HTN for patients in whom combination therapy is appropriate. Reduce the risk of stroke in patients w/ HTN &...

1  /  20
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 11 Dec 2020

Treatment with the nonsteroidal, selective mineralocorticoid receptor antagonist finerenone reduced chronic kidney disease (CKD) progression and cardiovascular (CV) event risk in patients with CKD and type 2 diabetes (T2D), according to the FIDELIO-DKD* study presented at ASN Kidney Week 2020.

Stephen Padilla, 22 Jun 2020
A dietary pattern (DP) characterized by high intakes of eggs, fish, milk, and other dairy products appears to confer protective benefits against incident cardiovascular disease (CVD) in women, reveals a study.